Specifically, our study identifies c‐Fos as a dominant driver of CEMIP expression in degenerated NPCs, suggesting a new avenue for therapeutic intervention targeting the AP‐1/CEMIP axis to mitigate IDD progression. The gene discussed is CEMIP; the disease is intervertebral disk degenerative disorder.